Gu S, Zaidi S, Hassan M, Mohammad T, Malta T, Noushmehr H, et al. Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis. Gastroenterology. 2020;158:238-252 pubmed publisher

Chen J, Shukla V, Farci P, Andricovich J, Jogunoori W, Kwong L, et al. Loss of the transforming growth factor-? effector ?2-Spectrin promotes genomic instability. Hepatology. 2017;65:678-693 pubmed publisher

Chen J, Yao Z, Chen J, Gi Y, Muñoz N, Kundra S, et al. TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome. J Clin Invest. 2016;126:527-42 pubmed publisher

Samsonov A, Zenser N, Zhang F, Zhang H, Fetter J, Malkov D. Tagging of genomic STAT3 and STAT1 with fluorescent proteins and insertion of a luciferase reporter in the cyclin D1 gene provides a modified A549 cell line to screen for selective STAT3 inhibitors. PLoS ONE. 2013;8:e68391 pubmed publisher

Schindeler A, Morse A, Peacock L, Mikulec K, Yu N, Liu R, et al. Rapid cell culture and pre-clinical screening of a transforming growth factor-beta (TGF-beta) inhibitor for orthopaedics. BMC Musculoskelet Disord. 2010;11:105 pubmed publisher

Catizone A, Ricci G, Tufano M, Perfetto B, Canipari R, Galdieri M. Hepatocyte growth factor (HGF) modulates Leydig cell extracellular matrix components. J Androl. 2010;31:306-13 pubmed publisher